These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10073307)

  • 1. Prevention of perinatal herpes: prophylactic antiviral therapy?
    Scott LL
    Clin Obstet Gynecol; 1999 Mar; 42(1):134-48; quiz 174-5. PubMed ID: 10073307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
    Hollier LM; Wendel GD
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004946. PubMed ID: 18254066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
    Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD
    Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on antiviral therapy for genital herpes infection.
    Geers TA; Isada CM
    Cleve Clin J Med; 2000 Aug; 67(8):567-73. PubMed ID: 10946451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
    Andrews WW; Kimberlin DF; Whitley R; Cliver S; Ramsey PS; Deeter R
    Am J Obstet Gynecol; 2006 Mar; 194(3):774-81. PubMed ID: 16522412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
    Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
    JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
    Kimberlin DW; Baley J; ;
    Pediatrics; 2013 Feb; 131(2):e635-46. PubMed ID: 23359576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P
    Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
    Leruez-Ville M; Ghout I; Bussières L; Stirnemann J; Magny JF; Couderc S; Salomon LJ; Guilleminot T; Aegerter P; Benoist G; Winer N; Picone O; Jacquemard F; Ville Y
    Am J Obstet Gynecol; 2016 Oct; 215(4):462.e1-462.e10. PubMed ID: 27083761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current recommendations for the treatment of genital herpes.
    Leung DT; Sacks SL
    Drugs; 2000 Dec; 60(6):1329-52. PubMed ID: 11152015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertical transmission of genital herpes: prevention and treatment options.
    Jones CA
    Drugs; 2009; 69(4):421-34. PubMed ID: 19323586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
    Kimberlin DW; Baley J; ;
    Pediatrics; 2013 Feb; 131(2):383-6. PubMed ID: 23378604
    [No Abstract]   [Full Text] [Related]  

  • 19. Genital herpes: antiviral therapy for symptom relief and prevention of transmission.
    Gupta R; Wald A
    Expert Opin Pharmacother; 2006 Apr; 7(6):665-75. PubMed ID: 16556084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes.
    Scott LL; Sanchez PJ; Jackson GL; Zeray F; Wendel GD
    Obstet Gynecol; 1996 Jan; 87(1):69-73. PubMed ID: 8532270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.